Integration between medical devices and information systems is a critical next step in utilizing technology to improve patient health and safety.
LaJolla, Calif. (PRWEB) May 09, 2012
Perminova, developer of web-based information systems for cardiology centers, has launched a strategic alliance with LifeWatch, the leading wireless cardiac monitoring service provider in the United States, to expand interoperability between medical monitoring devices and information technology in cardiac electrophysiology.
Under the arrangement, Perminova EP, the information system designed for electrophysiology, will integrate reports from LifeWatch’s cardiac monitoring and telemetry products directly into Perminova’s cloud-based system. This will provide physicians, nurses, technologists and other staff with a single source for patient information. Future development will also allow clinicians to order LifeWatch cardiac monitoring studies directly from Perminova systems.
The integration process begins with data uploading from a patient prescribed with one of LifeWatch’s suite of advanced ambulatory cardiac telemetry and standard cardiac event monitors to the LifeWatch data center. The LifeWatch data center then pushes the data to Perminova’s database to be matched with patients’ individual files. From there, the data is used by EP lab clinicians and becomes part of the health system’s electronic medical record. This entire process is electronic, greatly reducing the risk of human error.
“The strategic relationship between Perminova and LifeWatch creates important benefits for patients and healthcare systems,” said Craig K. Collins, President and CEO of Perminova. “On a daily basis, it will streamline workflow and improve patient safety in cardiac procedures. In a larger sense, medical device integration between Perminova and LifeWatch creates true interoperability, one of the primary objectives in the advancement of health information technology today.”
Said Dr. Yacov Geva, Chairman and CEO of LifeWatch AG: “Integration between medical devices and information systems is a critical next step in utilizing technology to improve patient health and safety. Medical device integration may also help relieve doctors, nurses and technologists of the burden of creating hard copy documentation, allowing them to spend more time on direct patient care.”
Perminova develops web-based cardiac information systems that manage scheduling, workflow, documentation and billing processes before, during and after cardiac procedures. Perminova’s system architecture also supports integration of medical devices and customization of robust data for research. Perminova’s web-based products are pioneering healthcare’s move from outdated client-server technology to modern-and-secure cloud computing.
LifeWatch is the nation’s leading ambulatory health monitoring services company, offering a comprehensive platform of innovative patient technologies and services that help physicians detect and analyze symptoms before they become major health problems. LifeWatch enables physicians to establish stronger connections with at-risk patients and provide better guidance to patients.
La Jolla, Calif.-based Perminova develops and markets web-based, cloud-based software for the nation’s leading cardiology centers. The company is pioneering healthcare’s move from outdated client-server technology to modern-and-secure cloud computing. Perminova products are electronic surgical records systems for cardiology, and they’re more robust, flexible and cost-effective than anything currently on the market. Its products improve charge-capture and efficiency, while automatically producing case reports and billing reports. Perminova seamlessly integrates with existing electronic medical records systems and deploys and upgrades easily via the web. Perminova’s architecture allows integration of medical devices and customization of robust data for medical research and clinical trials. Currently, Perminova EP is used at Mount Sinai Medical Center in New York and the UC San Diego Health System.
About LifeWatch AG
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and solution company, specializing in advanced telehealth systems and wireless remote patient monitoring services. LifeWatch services cater to individuals, ranging from high-risk and chronically ill patients, to consumers of health and wellness products. LifeWatch has subsidiaries in the United States, the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG is the parent company of LifeWatch Services Inc., a leading US-based cardiac monitoring service provider, and manufacturer of telecardiology products. LifeWatch is also introducing a new program for Home Sleep Testing of Obstructive Sleep Apnea (OSA) patients under the brand name NiteWatch.